Form 4: Scholar Rock Holding Corp: Chief Medical Officer Jing L. Marantz Reports Transactions

Jing L. Marantz, Chief Medical Officer of Scholar Rock Holding Corp, reports acquisition and disposal of common stock and stock options.

Summary

• On March 10, 2025, Jing L. Marantz, the Chief Medical Officer of Scholar Rock Holding Corp, reported transactions involving the company's securities.
• Marantz acquired 34,285 shares of common stock through restricted stock units (RSUs) at a price of $0.
• These RSUs vest in four annual installments starting February 15, 2026, contingent upon continued service with the Issuer.
• Marantz also acquired 45,715 stock options with an exercise price of $35.15, vesting quarterly over four years starting April 1, 2025.
• Following these transactions, Marantz beneficially owns 101,485 shares of common stock (including 88,927 RSUs) and 45,715 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions by an officer. The acquisitions could be seen as a positive, but it's a routine filing.

Positives

• The acquisition of stock options and RSUs by the Chief Medical Officer could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedules for both the RSUs and stock options are contingent upon continued service with the Issuer, suggesting an expectation of ongoing involvement by the reporting person.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and prospects.

Stakeholder Impact

• The transactions reported may influence investor sentiment regarding the company's prospects.

Key Dates